Franklin Resources
MACK

Franklin Resources’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Franklin Resources’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-469,793
Closed -$2.98M – 1583
2018
Q1 		$2.98M Hold
469,793
– – ﹤0.01% 1124
2017
Q4 		$3.79M Sell
469,793
-33,936
-7% -$316K ﹤0.01% 1119
2017
Q3 		$5.76M Sell
503,729
-2
-0% -$21 ﹤0.01% 1040
2017
Q2 		$4.91M Hold
503,731
– – ﹤0.01% 1084
2017
Q1 		$12.2M Hold
503,731
– – 0.01% 917
2016
Q4 		$16.2M Buy
503,731
+338,704
+205% +$14.4M 0.01% 842
2016
Q3 		$8.24M Hold
165,027
– – ﹤0.01% 1011
2016
Q2 		$7M Buy
+165,027
New +$8.99M ﹤0.01% 1036

Other funds holding MACK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return